Controlled release of an endostatin peptide using chitosan nanoparticles-Reference-Cited by-同舟云学术

Controlled release of an endostatin peptide using chitosan nanoparticles

Published:2017-03-11 Issue:3 Volume:90 Page:417-424
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Ebrahimi Samani Sanaz¹^ORCID,Seraj Zahra¹,Naderimanesh Hossein²,Khajeh Khosro³,Esmaeili Rastaghi Ahmad Reza⁴,Droudi Taher⁵,Kolivand Peirhosein⁵,Kazemi Hadi⁵,Asghari S. Mohsen¹

Affiliation:

1. Department of Biology; Faculty of Science; University of Guilan; Rasht Iran

2. Department of Biophysics; Faculty of Biological Sciences; Tarbiat Modares University; Tehran Iran

3. Department of Biochemistry; Faculty of Biological Sciences; Tarbiat Modares University; Tehran Iran

4. Department of Parasitology; Pasteur Institute of Iran; Tehran Iran

5. Shefa Neuroscience Research Center; Khatam Alanbia Hospital; Tehran Iran

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.12959/fullpdf

Reference48 articles.

1. Cancer Treatment Using Peptides: Current Therapies and Future Prospects

2. Peptide and protein drug delivery to and into tumors: challenges and solutions

3. Is the oral route possible for peptide and protein drug delivery?

4. Microgels and microcapsules in peptide and protein drug delivery

5. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial and in vitro anticancer activities of the antimicrobial peptide NRC‐07 encapsulated in chitosan nanoparticles;Journal of Peptide Science;2023-10-19

2. Cytomodulin-10 modified GelMA hydrogel with kartogenin for in-situ osteochondral regeneration;Acta Biomaterialia;2023-10

3. Particle carriers for controlled release of peptides;Journal of Controlled Release;2023-08

4. CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice;International Journal of Pharmaceutics;2023-04

5. Nanoparticles as a Therapeutic Approach for Tumor Angiogenesis;Innovative Approaches for Nanobiotechnology in Healthcare Systems;2022